Complement activation following oxidative stress (Q33852682)

29 July 2017

1 reference

title

Complement activation following oxidative stress (English)

1 reference

29 July 2017

C D Collard

1

1 reference

29 July 2017

R Lekowski

2

1 reference

29 July 2017

J E Jordan

3

1 reference

29 July 2017

A Agah

4

1 reference

29 July 2017

G L Stahl

5

1 reference

29 July 2017

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

36

1 reference

29 July 2017

issue

13-14

1 reference

29 July 2017

page(s)

941-948

1 reference

Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement activation following reoxygenation of hypoxic human endothelial cells: role of intracellular reactive oxygen species, NF-kappaB and new protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Reoxygenation of Hypoxic Human Umbilical Vein Endothelial Cells Activates the Classic Complement Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

C5a-induced expression of P-selectin in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement plays an essential role in shock following intestinal ischaemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Ancient origin of the complement lectin pathway revealed by molecular cloning of mannan binding protein-associated serine protease from a urochordate, the Japanese ascidian, Halocynthia roretzi

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Isolation and characterization of a mannan-binding protein from rabbit serum

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Soluble complement receptor type I limits damage during revascularization of ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Endothelium-dependent microvascular responses to activated complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Rapid induction of neutrophil–endothelial adhesion by endothelial complement fixation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Membrane proteins that protect against complement lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Requirement and role of C5a in acute lung inflammatory injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Hypoxia induces endothelial cell synthesis of membrane-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement localization and mediation of ischemic injury in baboon myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Human C4-binding protein. I. Isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement activation mediates intestinal injury after resuscitation from hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

A second serine protease associated with mannan-binding lectin that activates complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Mannose-binding lectin: the pluripotent molecule of the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

The lectin pathway of complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Complement depletion improves neurological function in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Immunoglobulins and complement components in human aortic atherosclerotic intima

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Mechanisms of endothelial cell killing by H2O2 or products of activated neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Effect of hypoxia on endothelial cell surface glycoprotein expression: modulation of glycoprotein IIIa and other specific surface glycoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Intestinal reperfusion injury is mediated by IgM and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Human heart generates complement proteins that are upregulated and activated after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

The first component of human complement (C1): Activation and control

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900116-9

7 January 2021

10.1016/S0161-5890(99)00116-9

Identifiers

DOI

1 reference

29 July 2017

1 reference